Quatramer™ encapsulation of dual‐targeted PI3‐Kδ/HDAC6 inhibitor, HSB‐510, suppresses growth of breast cancer

Multiple studies have shown that the progression of breast cancer depends on multiple signaling pathways, suggesting that therapies with multitargeted anticancer agents will offer improved therapeutic benefits through synergistic effects in inhibiting cancer growth. Dual‐targeted inhibitors of phosp...

Descripción completa

Detalles Bibliográficos
Autores principales: Tiwari, Sachchidanand, Liu, Suiyang, Anees, Mohd, Mehrotra, Neha, Thakur, Ashish, Tawa, Gregory J., Grewal, Gurmit, Stone, Richard, Kharbanda, Surender, Singh, Harpal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2023
Materias:
Regular Issue Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10487321/
https://www.ncbi.nlm.nih.gov/pubmed/37693068
http://dx.doi.org/10.1002/btm2.10541

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10487321/
https://www.ncbi.nlm.nih.gov/pubmed/37693068
http://dx.doi.org/10.1002/btm2.10541

Ejemplares similares